Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Repeated Dose Study of NPC-22 in Healthy Adult Males
jRCT2031210169Phase 1Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in hypersalivation comparing NPC-22 Tape with Placebo Tape (2 arms). Primary endpoint: Safety and tolerability. Started Jul 2021; status: completed.
02
Drugs
scopolamine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on jRCT2031210169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210169.